Holds one valid CEP for haloperidol decanoate, filing since 2025. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 14 markets.
Holds one valid CEP for haloperidol decanoate, filing since 2025. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 14 markets.
Holds one valid CEP for haloperidol decanoate, filing since 2014. Its GMP is recognised in 7 markets.
Holds one valid CEP for haloperidol decanoate, filing since 2022. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 4 markets.
Registered with SFDA (Saudi Arabia) for haloperidol decanoate. Its GMP is recognised in 1 market.
Registered with SFDA (Saudi Arabia) for haloperidol decanoate.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
Open the full list with a free accountThe order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free